Personal and Home Care Products
CIRS Group
Medical Devices
C&K Testing
Carbon Neutrality
Every Tuesday throughout February we will present a series of webinars on cosmetics regulations in China. We will provide you with an overview and cover the process for NMPA submissions. We will also give details on how to handle new ingredients and finished cosmetic products in China. These will be freely available to our clients and our regulatory network. And registrants will gain access to a free one-hour regulatory clinic with a member of our team.
We’ve translated a selection of some of the latest FAQs on cosmetics registration and filing in China with a focus on cosmetics efficacy to help you understand the current requirements.
On January 16, 2023, CIRS Group announced the opening of a new office in Shanghai, as it continues its expansion in the global marketing and service layout. Located in the heart of Pudong, the central Shanghai business district, Shanghai Office will devote itself to providing timely and sound product compliance services and solutions to clients in Shanghai or surrounding areas.
On December 29, 2022, US President Biden signed into law the Food and Drug Omnibus Reform Act (FDORA Act), which included the Modernization of Cosmetics Regulation Act of 2022 (MOCRA Act). This is the first significant amendment to American cosmetics regulations since 1938. Compared with the current Federal Food, Drug and Cosmetic Act (FDC Act), MOCRA Act forces cosmetic enterprises to register their facilities and maintain records for their products.
FAQs on Cosmetics Registration and Filing in China-Safety Assessment
On December 15, 2022, the Scientific Committee on Consumer Safety (SCCS) issued a preliminary opinion on salicylic acid (CAS No. 69-72-7) to assess the safety of salicylic acid in cosmetics for public comments. The deadline for the public consultation is February 17, 2023.
On November 11, 2022, the European Commission issued Regulation (EU) 2022/2195, amending the requirements of European Cosmetics Regulation (EC) No 1223/2009 on the use of Humosalate and Resorcinol, and adding the restrictions on the use of Butylated Hydroxytoluene, Acid Yellow 3 and HAA299 (nano and non nano forms). This revision mainly refers to the scientific opinions issued by the Scientific Committee on Consumer Safety (SCCS) in 2021. This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union.
FAQs from Beijing Cosmetics Review and Inspection Center on Ordinary Cosmetics Filing
CIRS Group is to host a free webinar on How to Register New Cosmetic Ingredients in China under CSAR on December 20-22. This free webinar mainly focuses on the latest regulatory requirements for new cosmetic ingredients in China as well as the pre- and post-filing requirements, to help related enterprises have a better understanding of the regulatory requirements under CSAR.
Since the outbreak of Covid-19 epidemic, disinfection products are far more widely used in daily lives in various scenarios. Enterprises have fastened their steps in new disinfection products development. To apply for a sanitary administrative license for “three new” disinfection products, related enterprises must: Judge whether your products are classified as “three new” disinfection products; Apply for notification under the requirements of Provisions on the Acceptance of Application for New Disinfection Products and the Application Guide issued by the National Health Commission. However, it is significantly difficult to notify a new disinfection product. There are uncertainties about the specific requirements, testing items, costs and application cycle for different products.